Emoxypine
3-hydroxypyridine derivative used in some countries, commonly as emoxypine succinate (Mexidol). Broad therapeutic claims rely heavily on regional, preclinical, or methodologically limited literature.
Pharmacokinetic model
A route-level PK model for emoxypine is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Medicine
- Suggested cadence
- once daily
Research behind this entry
-
Promising effects of emoxypine and its succinate derivative in the management of various diseases-with insights on recent patent applications
Narrative review surveyed free emoxypine, its succinate derivative, diverse experimental indications, and patents. It does not provide high-certainty clinical efficacy or a single transferable PK profile.
-
Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus
Experimental diabetes study evaluated several compounds and behavioral outcomes. It does not establish antidepressant or anxiolytic efficacy in humans without diabetes.
2 published studies referenced in the app, each with a plain-language summary.